Cargando…

AZGP1 inhibits soft tissue sarcoma cells invasion and migration

BACKGROUND: One of the major challenges in soft tissue sarcomas is to identify factors that predict metastasis. AZGP1 is a potential biomarker of cancer progression, but its value in soft tissue sarcomas remains unknown. The aim of this study is to determine the expression level of AZGP1 in soft tis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jiayong, Han, Haibo, Fan, Zhengfu, El Beaino, Marc, Fang, Zhiwei, Li, Shu, Ji, Jiafu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778744/ https://www.ncbi.nlm.nih.gov/pubmed/29357838 http://dx.doi.org/10.1186/s12885-017-3962-5

Ejemplares similares

Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma
por: Liu, Jiayong, et al.
Publicado: (2021)

Target therapy for metastatic alveolar soft part sarcoma: a retrospective study with 47 cases
por: Liu, Jiayong, et al.
Publicado: (2020)

Clinical features and therapeutic outcomes of alveolar soft part sarcoma in children: A single-center, retrospective study
por: Tan, Zhichao, et al.
Publicado: (2022)

Associations of chemo- and radio-resistant phenotypes with the gap junction, adhesion and extracellular matrix in a three-dimensional culture model of soft sarcoma
por: Bai, Chujie, et al.
Publicado: (2015)

Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma
por: Liu, Jiayong, et al.
Publicado: (2022)

Decreased Expression of AZGP1 Is Associated with Poor Prognosis in Primary Gastric Cancer
por: Huang, Chun-yu, et al.
Publicado: (2013)

AZGP1 Up-Regulation is a Potential Target for Andrographolide Reversing Radioresistance of Colorectal Cancer
por: Fang, Ye-Ying, et al.
Publicado: (2022)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Surgical drainage after limb salvage surgery and endoprosthetic reconstruction: is 30 mL/day critical?
por: Liu, Jiayong, et al.
Publicado: (2021)

Nanomaterial Technology and Soft Tissue Sarcomas
por: Zhou, Changkai, et al.
Publicado: (2022)

Clinical Significance of Preoperative Serum High Density Lipoprotein Cholesterol Levels in Soft Tissue Sarcoma
por: Que, Yi, et al.
Publicado: (2015)

Olaratumab’s failure in soft tissue sarcoma
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

The Therapeutic Potential of Zinc-Alpha2-Glycoprotein (AZGP1) in Fibrotic Kidney Disease
por: Sörensen-Zender, Inga, et al.
Publicado: (2022)

Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma
por: Que, Yi, et al.
Publicado: (2015)

Retroperitoneal soft tissue sarcoma
por: Zepeda, Ernesto, et al.
Publicado: (2007)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Soft Tissue Sarcomas of the Kidney
por: Köhle, Olivia, et al.
Publicado: (2015)

Bone and Soft Tissue Sarcoma
por: Ruggiero, Antonio
Publicado: (2020)

Trabectedin for soft tissue sarcoma
Publicado: (2021)

Prognostic significance of histological invasion in high grade soft tissue sarcomas
por: Tsukushi, Satoshi, et al.
Publicado: (2014)

Efficacy and safety of apatinib in patients with untreated or chemotherapy-refractory soft tissue sarcoma: a multicenter, phase 2 trial
por: Yu, Wenxi, et al.
Publicado: (2022)

Changes in AZGP1 Serum Levels and Correlation With Pulse Wave Velocity After Kidney Transplantation
por: Kraemer, Thomas Daniel, et al.
Publicado: (2021)

Prognostic factors for survival in soft tissue sarcoma.
por: el-Jabbour, J. N., et al.
Publicado: (1990)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

Knockdown of Kif20a inhibits growth of tumors in soft tissue sarcoma in vitro and in vivo
por: Zhu, Zhenhua, et al.
Publicado: (2020)

Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma
por: Liang, Yao, et al.
Publicado: (2018)

Delays in Referral of Soft Tissue Sarcomas
por: Johnson, G. D., et al.
Publicado: (2008)

Paediatric bone and soft tissue sarcoma
por: Anderson, J
Publicado: (2007)

Studies of an alveolar soft tissue sarcoma.
por: Udekwu, F. A., et al.
Publicado: (1965)

Management of extremity soft tissue sarcomas
por: Puri, Ajay, et al.
Publicado: (2011)

Application of Proteomics to Soft Tissue Sarcomas
por: Kondo, Tadashi, et al.
Publicado: (2012)

Guidelines for the Management of Soft Tissue Sarcomas
por: Grimer, Robert, et al.
Publicado: (2010)

Pazopanib: Approval for Soft-Tissue Sarcoma
por: Nguyen, Diana T., et al.
Publicado: (2013)

Multidisciplinary Management of Soft Tissue Sarcoma
por: Nystrom, Lukas M., et al.
Publicado: (2013)

Pazopanib for the treatment of soft-tissue sarcoma
por: Heudel, Pierre, et al.
Publicado: (2012)

Immunotherapy for Bone and Soft Tissue Sarcomas
por: Uehara, Takenori, et al.
Publicado: (2015)

Pediatric bone and soft-tissue sarcomas
por: McCarville, Beth
Publicado: (2015)

Follow-up in soft tissue sarcomas
por: Rutkowski, Piotr, et al.
Publicado: (2014)

ATYPICAL PRESENTATION OF SOFT TISSUE SARCOMA
por: Rizzo, Victoria, et al.
Publicado: (2017)

Imaging in retroperitoneal soft tissue sarcoma
por: Messiou, Christina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_krjkcdsobg0lpqqghd3n6hss1m